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Abstract
Background: Environmental processes in ecosystems are dynamically altered by several metabolic responses in
microorganisms, including intracellular sensing and pumping, battle for survival, and supply of or competition for
nutrients. Notably, intestinal bacteria maintain homeostatic balance in mammals via multiple dynamic biochemical
reactions to produce several metabolites from undigested food, and those metabolites exert various effects on mammalian
cells in a time-dependent manner. We have established a method for the analysis of bacterial metabolic dynamics in real
time and used it in combination with statistical NMR procedures.
Methodology/Principal Findings: We developed a novel method called real-time metabolotyping (RT-MT), which performs
sequential
1H-NMR profiling and two-dimensional (2D)
1H,
13C-HSQC (heteronuclear single quantum coherence) profiling
during bacterial growth in an NMR tube. The profiles were evaluated with such statistical methods as Z-score analysis,
principal components analysis, and time series of statistical TOtal Correlation SpectroScopY (TOCSY). In addition, using 2D
1H,
13C-HSQC with the stable isotope labeling technique, we observed the metabolic kinetics of specific biochemical
reactions based on time-dependent 2D kinetic profiles. Using these methods, we clarified the pathway for linolenic acid
hydrogenation by a gastrointestinal bacterium, Butyrivibrio fibrisolvens. We identified trans11, cis13 conjugated linoleic acid
as the intermediate of linolenic acid hydrogenation by B. fibrisolvens, based on the results of
13C-labeling RT-MT
experiments. In addition, we showed that the biohydrogenation of polyunsaturated fatty acids serves as a defense
mechanism against their toxic effects.
Conclusions: RT-MT is useful for the characterization of beneficial bacterium that shows potential for use as probiotic by
producing bioactive compounds.
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Introduction
A huge number of microorganisms are known to colonize and
form complex microbial ecosystems within the human and animal
gut [1–5]. It is generally accepted that microbial ecosystems
associated with humans or animals have a direct influence on the
host’s health. Gut microbiota possess a number of metabolic
capabilities that are lacking in the host and thus, can be viewed as
indispensable to the maintenance of health. Gut microbes
contribute to host nutrition by producing organic acids from
undigested carbohydrates and by synthesizing bioactive substanc-
es, including vitamins [6,7]. Intestinal bacteria and their
metabolites, including short-chain fatty acids (SCFAs), butyric
acid in particular, exert significant physiological effects on the host
by controlling the differentiation and proliferation of intestinal
epithelial cells, providing energy to epithelial cells, modulating the
immune system, and protecting against pathogens [6–10]. An
imbalance of intestinal microbiota can predispose individuals to a
variety of disease states ranging from inflammatory bowel disease
to allergy and obesity [3,4,11].
Recently, many probiotics have emerged and their effects on
human health have been partially demonstrated [12–15]. As a
single probiotic bacterium can exert several effects on human
health mainly through the improvement of host innate immune
responses by producing several bioactive substances[16–21], an
understanding of the metabolic dynamics of purified bacterium is
absolutely essential. However, the mechanisms underlying their
effects have not been well elucidated and thus, the functional
analysis of probiotics is eagerly anticipated. Because metabolites
that can be utilized similarly by host cells and bacterial cells are
PLoS ONE | www.plosone.org 1 March 2009 | Volume 4 | Issue 3 | e4893considered to be one of the most important factors to help us
understand the effectiveness of probiotics [22,23], we need to
establish a method for the analysis of metabolic dynamics.
Since bacteria grow in the gut, it is desirable to analyze their
metabolic dynamics at the growth phase to elucidate their ability
to produce organic acids and physiologically active substances.
The multiple high-throughput metabolic analysis of Escherichia coli
K12 knockdown system has been reported [24]; however, it
requires bacterial whole genomic information and knockdown
systems, and is not easily applicable to the estimation of bacterial
metabolic dynamics.
To use bacteria as probiotics, it is necessary to screen their
characteristics, such as pH resistance and the ability to produce
bioactive substances [25,26]. As screening methods are diverse and
usually complicated, an appropriate strategy is desired. By
characterizing bacteria based on their metabolic profiles, we
would be able to know and estimate their ability to produce
bioactive substances or their metabolic dynamics in response to
environmental factors, such as nutrients and chemicals. Accord-
ingly, the development of a universal bacterial evaluation system is
highly awaited in food science technology.
To understand bacterial metabolic dynamics, several analytical
strategies having notable technological features have been
introduced [27,28]. In addition, an important concept that is
based on the global analysis of environmental metabolites, the so-
called metabolic phenotype, has been reported [29–33]. However,
these strategies are insufficient because they can observe only
metabolites at a certain growth stage of living cells or under certain
environmental conditions. In other words, those strategies provide
only a ‘‘static’’ view of metabolic aspects. Most enzyme reactions
are completed within a few seconds, while metabolic reactions
occur on a time scale of minutes to hours and changes in microbial
growth occur on a time scale of hours to days. Several techniques
for monitoring living cells have been reported, including in situ, ex
vivo, and in vivo NMR [34–43]. However, efficient approaches that
combine such real-time dependent (in vivo) events and statistical
approaches have not been investigated.
We have reported that a gastrointestinal bacterium, Butyrivibrio
fibrisolvens, produces conjugated linoleic acid (CLA) and conjugated
linolenic acid (CLNA) from linoleic acid (LA) and alpha-linolenic
acid (LNA), respectively [44–47]. CLA and CLNA produced by B.
fibrisolvens are known as health-promoting substances because of
their beneficial effects on human health [48–53]. However, the
metabolic dynamics of B. fibrisolvens, including CLA and CLNA
production, is not well understood. Here we developed a novel
profiling technique called real-time metabolotyping (RT-MT) to
understand and evaluate metabolic dynamics when used in
combination with real-time and statistical NMR analysis methods.
As a result of performing
13C-labeling RT-MT experiments, we
clarified the LNA hydrogenation pathway of B. fibrisolvens based on
our accumulated knowledge in NMR analyses and stable isotope
labeling techniques [54–58].
Results and Discussion
Development of RT-MT to understand bacterial
metabolic dynamics and possible applications
We have developed RT-MT to understand and evaluate the
metabolic dynamics of several bacterial strains (Fig. 1). The most
important point of this method is that the time-dependent
Figure 1. Development of real-time metabolotyping (RT-MT) to analyze bacterial metabolic dynamics. In vivo
1H-NMR (right) and two-
dimensional
1H,
13C-HSQC with
13C labeled substrate technique (2D-
13C-HSQC) (left) were continuously conducted during bacterial growth in an NMR
tube at 37uC, and the profiling data were processed and analyzed by several statistical methods, such as Z-score analysis, principal components
analysis (PCA), and time series of statistical total correlation spectroscopy (STOCSY). From the results of statistical analyses of In vivo
1H-NMR profiling
data, we extracted meaningful data related to time-varying information. Furthermore, from the results of in vivo 2D-
13C-HSQC profiling data, we
revealed the metabolic kinetics of specific metabolic reactions.
doi:10.1371/journal.pone.0004893.g001
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1H-NMR and
1H,
13C-HSQC sequential
observations during bacterial growth in an NMR tube are
calculated and evaluated with several statistical methods, such as
Z-score analysis, principal components analysis (PCA), and
statistical total correlated spectroscopy (STOCSY). It is considered
that the statistical analyses of time-dependent metabolic profiles
would show meaningful biological data related to metabolic
dynamics. In addition, time-dependent two-dimensional
1H,
13C-
HSQC with
13C labeled substrates (2D-
13C-HSQC) profiles could
be used to generate three-dimensional metabolic kinetic profiles.
Time-dependent 2D-
13C-HSQC can provide very detailed
information of specific metabolic dynamics. As anaerobic
conditions can be easily created in NMR tubes, RT-MT can be
applied to the analysis of anaerobic environments, such as soil,
industrial plant, and animal gut. RT-MT is expected to improve
our understanding of metabolic dynamics that would be necessary
for the extraction of particular characteristics of metabolic
changes.
Use of time-dependent
1H-NMR RT-MT to assess bacterial
characteristics
a) Z-score analysis of B. fibrisolvens strains. Z-score
analysis of three B. fibrisolvens strains revealed their metabolic
dynamics, including time-varying factors (Fig. 2). All samples
showed remarkable changes of the chemical shifts in the 1 to
4 ppm region, which were derived from lipids, organic acids, and
sugars, and around 8 ppm, which were derived from formic acid.
In particular, signals around 2 ppm, which were attributed mainly
to acetic acid present in abundance, were slightly shifted downfield
with decreasing culture pH. A negative correlation was observed
between glucose concentration, which was calculated from the
1H-
NMR standard curve (data not shown), and bacterial growth rate
(SI Fig. S1). It was possible to calculate the transition to acidic
culture pH due to organic acid production by bacteria from the
chemical shift changes of bacterial metabolites containing a
carboxylic group (SI Fig. S2). Furthermore, Z-score analysis
clearly showed changes in the chemical shifts of metabolites
present in small amounts, which appeared as unidentified signals
in the low field region (8.3–8.6 ppm) during bacterial growth.
Interestingly, the presence or absence of linoleic acid (LA) or
linolenic acid (LNA) contributed more significantly to the
difference in Z-score profiles than the difference in strain under
the same conditions. Anaerobic B. fibrisolvens strains exhibit
different metabolic activities of and tolerance activities to
exogenous lipids related to CLA production [47], and the
remarkable differences of the Z-score profiles among control,
LA, and LNA conditions are a reflection of the difference in
metabolic activities of the strains. From these findings, we
speculated that RT-MT may be applicable to chemical biological
research [59,60] as well as to silent phenotype analysis [61] to
screen for objective chemicals and phenotypes, because RT-MT
can easily monitor metabolic changes based on specific reactions
and responses by the addition of several compounds.
In cultures with LA or LNA, Z-score profiles mainly around the
1 to 4 ppm region were changed compared to the cultures without
LA or LNA (Fig. 2). In particular, Z-score variations around
3.5 ppm represent variations in the amounts of sugars. The results
show that the relative sugar consumption rates of MDT-5 and A38
strains grown in the presence of LNA, as well as of A38 grown in
the presence of LA, were lower than those of control cultures. This
result suggests that fatty acids (FAs) inhibit bacterial growth, as has
been reported previously [62]. However, the growth of MDT-10
was not markedly inhibited by LA or LNA. Our past data showed
that MDT-10 can rapidly metabolize LA and LNA to vaccenic
acid (VA), which is less toxic than LA and LNA to bacteria [45].
Therefore, MDT-10 is considered to be resistant to FAs. From
these results, we consider that RT-MT is useful for the rough
visualization of bacterial metabolic dynamics in response to
exogenous effectors.
b) PCA of B. fibrisolvens strains. Different from Z-score
analysis, it is possible to detect characteristic metabolites by PCA.
Interestingly, the differences in PCA profiles were more
Figure 2. Z-score analysis of time-dependent
1H-NMR profiles of three B. fibrisolvens strains incubated with or without LA or LNA. A
total of 120 continuously acquired in vivo
1H-NMR spectra were used in each Z-score analysis. MDT-10, MDT-5, and A38 were grown in anaerobic
culture (control), with 2.5 mM LA, or with 2.5 mM LNA. Asterisks mean low concentration (0.6 mM) of FAs, because MDT-5 did not grow in the
presence of 2.5 mM LA or 2.5 mM LNA, and A38 did not grow in the presence of 2.5 mM LNA. Data are representative of three independent
experiments. Contour levels (Z-score values) defined by different colors are indicated at the bottom.
doi:10.1371/journal.pone.0004893.g002
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medium conditions (Fig. 3-A). The PCA profiles of the three
strains revealed that the metabolic characteristics of MDT-10 and
MDT-5 were similar, while those of A38 were quite different. We
calculated the first two components that contained principal
components 1 and 2 contributing to 77.0% and 11.6% of the data
variance, respectively. The strains were well separated primarily in
PC2 and appeared to form two groups of A38 and of MDT-10
and MDT-5. In contrast, PC1 was dominated by the time course,
which is common to the three strains. The spectral regions that
contributed most to the difference between the two groups are
shown in the corresponding loading plot (Fig. 3-B). Metabolites
that exerted the greatest influence on this separation were lactate
and glucose in PC1 and butyrate, acetate, and formate in PC2
(Fig. 3-B). As the three strains grew, they consumed glucose and
produced lactate; however, butyrate, acetate, and formate
production was different between the two groups. It is well
known that B. fibrisolvens strains could be classified into Type I
(high butyrate and formate production) or Type II (high lactate
production) based on their fermentation products but not their
16S rDNA sequences [63–65]. It has been reported that these
differences may be the basis for genetic differences related to the
butyrate production pathway [65]. Therefore, this analytical
method could be used to characterize bacterial fermentation
patterns derived from functional genetic information.
c) STOCSY analysis of B. fibrisolvens MDT-10. In order
to clarify the pathway of LNA metabolism by B. fibrisolvens MDT-
10, we next analyzed the time series of STOCSY spectra [66], and
the results showed time-dependent metabolic changes in bacterial
growth at hourly intervals (SI Fig. S3). For the spectra obtained
without LNA, a negative correlation was observed between
glucose (around 3.5 ppm) and organic acids (around 1.5 ppm) in
the spectra at 3 to 6 h; the correlation corresponded to the activity
during the growth period of MDT-10, because the growth reached
a maximum after 6 h (SI Fig. S1). Moreover, the negative
correlation vanished after 8 h in the spectra of cultures grown
without LNA, whereas the negative correlation in the spectra of
cultures grown with LNA existed until 9 h in spite of the addition
of LNA, which has a stronger growth inhibitory effect than LA.
Negative correlations in the spectra of the cultures grown with
LNA were low at 3 to 9 h compared to control values (grown
without LNA), suggesting that the growth of MDT-10 was
inhibited by LNA, and that MDT-10 grew after LNA was
metabolized to VA, which is much less cytotoxic than LNA [47].
Analyzing the metabolic response of MDT-10 to LNA, signals
in the 1 to 3 ppm region were greatly changed and some of the
compounds were successfully identified. For example, several
organic acids produced from glucose were identified, and some
signals, such as those at 1.2, 1.5, 1.8, and nearby 2.8 ppm, showed
a positive correlation with glucose consumption (Fig. 4). As those
signals were assumed to be derived from LNA or its metabolites,
we next performed 2D
1H,
13C-HSQC analysis using U-
13C18 LA
and U-
13C18 LNA.
Utilization of time-dependent 2D-
13C-HSQC RT-MT to
narrow down biochemical reactions analyzed
To monitor the specific metabolic dynamics, we developed
time-dependent 2D-
13C-HSQC with U-
13C18 LA and U-
13C18
LNA. As the time-dependent 2D-
13C-HSQC profiles could be
used to generate three-dimensional metabolic profiles, it is possible
to understand very detailed information of specific metabolic
kinetics. It is well known that NMR signal intensities can be
altered by such factors as the mobility of molecules, pH, and
sample homogeneity [67–73]. However, our results indicated that
the normalized signal intensities of
13C-labeled substrate were little
affected by bacterial optical density, differences in NMR data
processing, and culture pH (SI Tables S1 and S2). In addition, the
variability of triplicate experiments was caused by differences in
the volume of pre-cultured bacterial medium that was initially
inoculated into the NMR tube. NMR tuning and shimming could
also change NMR signal intensities and line widths; however, we
Figure 3. Principal components analysis (A) and loading plot analysis (B) of three strains of B. fibrisolvens. MDT-10 (red), MDT-5 (blue),
and A38 (purple) are shown. Data under conditions of LA addition (open squares), LNA addition (close squares), or no addition (close circles) were
calculated. Data are representative of three independent experiments. (A) Hourly
1H-NMR profiling data of three strains of B. fibrisolvens incubated
with or without LA or LNA were analyzed. Contributions of PC1 and PC2 were 77.0% and 11.6%, respectively. All 0 h samples were assembled at the
left side of Figure 3A, indicating that metabolic conditions before bacterial growth were similar. However, after 10 h, the samples were located in the
right side of Figure 3A, suggesting that PC1 means bacterial growth and PC2 means metabolic differences among B. fibrisolvens strains. (B) Blue peaks
and words indicate PC1 contribution and those in red indicate PC2 contribution. The 4.2–5.2 ppm region was omitted to eliminate the effects of
imperfect water suppression.
doi:10.1371/journal.pone.0004893.g003
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Therefore, the results of our kinetic analysis were highly reliable.
In the case of RT-MT with U-
13C18 LA and U-
13C18 LNA, we
state two reasons why the signal intensities were largely unaltered.
First, the culture media contained large amounts of molecules,
including sugars, peptides, organic acids, minerals, and vitamins,
for bacterial growth [21]. Second, to dissolve U-
13C18 LA and
U-
13C18 LNA in culture media, they were mixed and adsorbed to
bovine serum albumin (BSA) [47]. It is for these two reasons that
we conclude that the signal intensities of U-
13C18 LA and U-
13C18
LNA were largely unaltered.
a) Dynamics of LA metabolism by B. fibrisolvens MDT-
10. It is well known that B. fibrisolvens hydrogenates LA and LNA
to VA in order to decrease their cytotoxicity [62]. Our past
findings also suggest that LA hydrogenation activity and tolerance
ability to LA are correlated [47]. When we monitored LA
metabolic kinetics of MDT-10 using time-dependent 2D-
13C-
HSQC RT-MT, we found that the growth rate of MDT-10 was
low at the initial stage of growth when LA concentration was high.
However, the growth rate increased gradually as LA was reduced
to VA through the transient accumulation of cis9, trans11-CLA (SI
Fig. S4). As mentioned above, LA or CLA hydrogenation to VA
may be a defense response. These results are consistent with our
past data; therefore, time-dependent 2D-
13C-HSQC RT-MT is
useful for understanding metabolic kinetics.
b) Dynamics of LNA metabolism by B. fibrisolvens MDT-
10. Our past work has demonstrated that the bacterial growth
inhibitory activity of unsaturated FAs increases with increasing
degree of unsaturation [47]. Therefore, we next analyzed the
metabolic dynamics of LNA, which is more unsaturated than LA,
using MDT-10. Similar to the case of LA (SI Fig. S4), MDT-10
growth was suppressed at the initial growth stage when LNA
concentration was high, but was gradually improved as LNA was
hydrogenated to VA (Fig. 5). The intermediates of LNA
hydrogenation were identified as CLNA, trans11, cis15–18:2 (t11,
c15–18:2), and VA. When similar analysis was performed with
MDT-5 and A38, the final product of LNA hydrogenation was
CLNA and t11, c15–18:2, respectively (Fig. 6-A). Previously, we
reported that strain TH1 produced CLNA and t11, c15–18:2 as
the intermediates of LNA hydrogenation [46], and we also
observed that strains ATCC19171 and ATCC51255 produced
CLNA and t11, c15–18:2 as intermediates (data not shown). Thus,
the LNA hydrogenation pathway may be similar among B.
fibrisolvens strains except A38 and MDT-5.
Figure 4. Time series of STOCSY analysis of B. fibrisolvens MDT-10 incubated with LNA. During these one-hour experiments, a total of
twelve continuously acquired in vivo
1H-NMR spectra were used for STOCSY analysis. Spectra appearing on the right side are the sum of the twelve in
vivo
1H-NMR spectra measured in every one-hour experiment. Contour levels (STOCSY correlations) defined by different colors are indicated at the
bottom. Blue represents high positive correlation and red represents low. Optical density (OD) is a measure of bacterial growth. Arrows indicate
butyrate (black), lactate (orange), acetate (pink), and ethanol (purple). Signals surrounded by green squares are assumed to be derived from LNA or its
metabolites. Data are representative of three independent experiments.
doi:10.1371/journal.pone.0004893.g004
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13C-HSQC RT-MT to
proteinfunctionalanalysisbased onbiochemical reactions:
LNA hydrogenation pathway in B. fibrisolvens MDT-10
WefoundpreviouslythatCLA-RfromMDT-10reducesCLNAto
t11, c15–18:2 but did not reduce t11, c15–18:2 to VA [44]. Therefore,
we surmised that t11, c15–18:2 is isomerized once to another form,
a n dt h e nr e d u c e dt oV A .W h e nM D T - 5 ,w h i c hh a sn oC L A - R
activity, was grown with t11, c15–18:2 that was produced from
U-
13C18 LNA by A38, only an unidentified 18:2 FA was produced
(Fig. 6-A), and A38 did not metabolize t11, c15–18:2 further (data not
shown). Meanwhile, MDT-10 converted the unidentified 18:2 FA
produced by MDT-5 into VA. These results are consistent with the
information for LNA metabolism described above.
The unidentified 18:2 FA produced by MDT-5 was shown to be
an isomer of t11, c15–18:2, as examined by gas chromatography-
mass spectrometry (GC-17A, Shimadzu Co., Kyoto, Japan) (data
not shown). This FA exhibited absorbance at 233 nm in reversed-
phase HPLC (Prominence, Shimadzu Co., Kyoto, Japan) (data not
shown), indicating that the FA has conjugated double bonds.
When we compared the structures of the intermediates produced
by U-
13C18 LNA hydrogenation by 2D
1H,
13C-HSQC profiling,
the unidentified 18:2 FA was found to have trans and cis double
bonds (SI Fig. S5). In addition, since purified CLA-R from MDT-
10 reduced this FA directly to VA, which has a trans-11 double
bond, this FA would have at least one trans-11 double bond (data
not shown). TOCSY analysis revealed that CH3 and CH of the
double bond of the unidentified 18:2 FA were correlated, whereas
CH3 and CH of the double bond of VA were not correlated,
suggesting that the double bonds of this FA are located at positions
11 and 13, respectively (SI Fig. S6). Thus, 18:2 FA was identified
as t11, c13-CLA. It has been suggested that conjugated 18:2
isomers in general have health-promoting activities [48]. t11, c13-
CLA was found in milk of cows grazing mountain pasture, which
is rich in LNA [74]. Taken together, we conclude that the LNA
hydrogenation pathway in the three B. fibrisolvens strains is as
shown in Fig. 6-B. It is noteworthy that the CLA-R from MDT-10
hydrogenates both CLNA and t11, c13-CLA.
It has been reported that LA isomerase (LA-I) purified from A38
isomerized not only LA to CLA but also LNA to CLNA [75–77]. As
mentioned above, our experiments with A38 showed that the final
product of LNA hydrogenation is t11, c15–18:2, indicating that LA-I
of A38 is unable to isomerize t11, c15–18:2 to other isomers, such as
t11, c13–18:2. Although we have not purified LA-I from MDT-10 or
MDT-5, their LA-I may be similarly unable to isomerize t11, c15–
18:2. Thus, we speculate that MDT-10 and MDT-5 have a specific
t11, c15–18:2 isomerase that differs from LA-I.
Possible applications to applied sciences
We demonstrated that metabolic changes of the three strains of
B. fibrisolvens in response to unsaturated FAs can be evaluated by
Figure 5. LNA metabolic dynamics of B. fibrisolvens MDT-10 analyzed by time-dependent 2D-
13C-HSQC RT-MT. The NMR tube was
anaerobically inoculated with B. fibrisolvens MDT-10 and U-
13C18 LNA (2.5 mM) was added to follow LNA hydrogenation reactions in in vivo 2D-
13C-
HSQC RT-MT. A: Typical 2D HSQC spectra (sequential growth at 0, 2, 3, and 4 hours) are shown. 2D HSQC spectra were observed every 8 minutes.
Arrows in upper panel indicate C-H structures corresponding to the signals. Signal intensities were calculated based on their standard curves. Arrows
pointing to lower panel (B) indicate 2D HSQC spectra measured at the indicated time point. B: LNA metabolic dynamics of B. fibrisolvens MDT-10
calculated from time-dependent 2D-
13C-HSQC RT-MT. LNA (black circles), CLNA (blue triangles), t11, c15–18:2 (pink diamonds), VA (green squares),
and bacterial growth (open red squares) are shown. Mean values of triplicate experiments are shown.
doi:10.1371/journal.pone.0004893.g005
Real-Time Metabolic Profiling
PLoS ONE | www.plosone.org 6 March 2009 | Volume 4 | Issue 3 | e4893RT-MT. Therefore, this method is a powerful tool for the
investigation and estimation of bacterial metabolic dynamics. By
monitoring bacterial metabolic dynamics in real time, we would be
able to understand their metabolic activities and evaluate their
effectiveness as candidates for probiotics. The characteristics of the
three B. fibrisolvens strains are as follows: MDT-5 has higher
CLNA-producing ability than the other two strains (Fig. 6-A), but
its growth is inhibited at high LA and LNA concentrations (Fig. 2).
A38 produces a large amount of butyrate having several
physiological activities [21], compared to the other two strains
(Fig. 3). MDT-10 metabolizes LA and LNA to VA and produces
t11, c13 conjugated FA from LNA (Figs. 2, 6, and SI Fig. S4). We
previously proposed that MDT-5 and MDT-10 may be beneficial
as probiotics for animals including humans, by acting to increase
CLA and CLNA production in the intestine [45,46], and that
MDT-10 may also be useful to augment butyrate production in
the intestine [21]. Thus, to improve bacterial production of
bioactive substances, a solid understanding of metabolic dynamics
is important.
RT-MT can be used to understand metabolic pathways and
may have applications in industry as an innovative bacterial
monitoring system. Bacterial fermentation products have been
examined for possible use as renewable energy and materials in the
biorefinery industry [78] and therefore, RT-MT might be
extended to strain screening, strain improvement, and evaluation
for metabolic engineering [36,79–81]. Further applications include
process monitoring in the food industry and environmental
management, including wine fermentation [82], lactobacillus
fermentation [82,83], and bioremediation [28]. It is considered
that the detection limit of metabolites by NMR is generally much
lower than that of other apparatuses, such as GC-MS and LC-MS.
However, the amounts of metabolites affecting human health,
such as SCFAs produced by colonized gut microbes, are
considerably high [84]. If only the quantification of metabolites
could be accomplished, we would be able to partially predict
metabolic pathways and use them in combination with genomic
information. Thus, in vivo NMR techniques are considered to be
useful for the characterization of bacterial strains, and our newly
proposed method, RT-MT, may open a new avenue for basic life
science, industry, and environmental management.
Materials and Methods
Bacterial strains, reagents, and culture conditions
Sources of B. fibrisolvens strains (A38, MDT-5, and MDT-10)
were described previously [45–47]. Unless otherwise stated, each
strain was grown in 30 mL serum vials containing growth medium
(15 mL) with 5 g/L glucose. Details of culture medium, growth
conditions, and procedures were as described previously [21,85].
In the case of in vivo NMR measurement, the strains were cultured
in a 5 mm NMR tube containing 1 mL of growth medium, 10%
(v/v) D2O, and 1 mM sodium 2,2- dimethyl-2- silapentane-5-
sulfonate (DSS).
U-
13C18 LA and LNA, D2O, and DSS were purchased from
Shoko Tsusho Ltd. (Tokyo, Japan). FAs were added as a mixture
with BSA, which was prepared as described previously [47].
1D and 2D NMR measurements
All NMR spectra were recorded on a Bruker DRX-500
spectrometer operating at 500.03 MHz
1H frequency with the
temperature of NMR samples maintained at 310 K. For 1D in vivo
1H-NMR, spectra were observed every 5 minutes and residual
water signals were suppressed by Watergate pulse sequence with
1.2 second repetitive time. 2D
13C-HSQC spectra were measured
every 8 minutes according to the method of Kikuchi and
Hirayama [86]. Briefly, 1D NMR spectra were measured on a
Bruker DRX-500 spectrometer equipped with a
1H inverse probe
with triple axis gradient. All 2D
13C-HSQC spectra were recorded
Figure 6. Metabolic dynamics of LNA and t11, c15–18:2 in three strains of B. fibrisolvens analyzed by time-dependent 2D-
13C-HSQC
RT-MT. A: When the initial OD was approximately 0.5, U-
13C18 LNA or t11, c15–18:2 (2.5 mM) was added to cultures to avoid growth inhibition. LNA
(black circles), CLNA (blue triangles), t11, c15–18:2 (pink diamonds), t11, c13–18:2 (orange circles), VA (green squares), and bacterial growth (open red
squares) are shown. A38 did not metabolize t11, c15–18:2 (data not shown). Mean values of triplicate experiments are shown. B: LNA hydrogenation
pathway of three strains of B. fibrisolvens deduced from the results of this study. Chemical structures and location of double bonds of LNA and its
metabolites are shown. Arrows indicate enzymes responsible for each reaction. Light blue, red, and dark blue arrows represent LNA isomerase, CLA-R,
and t11, c15–18:2 isomerase, respectively.
doi:10.1371/journal.pone.0004893.g006
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1H inverse
cryogenic probe with Z-axis gradient. A total of 32 complex f1
(
13C) and 1024 complex f2 (
1H) points were recorded with 8 scans
per f1 increment. Spectral widths were 2,640 Hz and 5000 Hz for
f1 and f2, respectively. To quantify signal intensities, a Lorentzian-
to-Gaussian window with a Lorentzian line width of 10 Hz and a
Gaussian line width of 15 Hz was applied in both dimensions,
prior to Fourier transformation. A fifth-order polynomial baseline
correction was subsequently applied in f1 dimension. The indirect
dimension was zero-filled to 512 points in the final data matrix.
NMR spectra were processed using NMRPipe software [87,88].
Quantitative statistical analysis of 1D
1H-NMR spectra
1D
1H-NMR data were reduced by subdividing spectra into
sequential 0.04 ppm designated regions between
1H chemical
shifts of 0.5 to 10.0. After exclusion of water resonance, each
region was integrated and normalized to the total of all resonance
integral regions. 2D spectral assignments were performed using
customized software (Chikayama and Kikuchi, unpublished data).
The Z-score matrix that was used to visualize sequential
changes of chemical shifts is defined as the matrix that has each
element of
Zij~ sij{SsjT
 
sj,
where sij is the intensity of the j-th bin in the i-th 1D spectrum, Æsjæ
is the average of all the intensities of the j-th bins in all the spectra,
and sj is the standard deviation of them. Any elements that had
intensity less than 3000 (arbitrary unit) in the final Z-score
matrices were replaced with zero.
PCA was run on R software. Data were visualized in the form of
PC score plots and loading plots. Each coordinate on the score
plot represents an individual sample and each coordinate on the
loading plot represents one NMR spectral data point related to
metabolites. Thus, the loading plots provide information on
spectral regions responsible for the positions of coordinates or
clusters of samples in the corresponding score plots.
STOCSY was also analyzed using Excel software, as described
by Cloarec et al. [66]. Briefly, a STOCSY spectrum was calculated
as a symmetric matrix in which an element at position (i, j)i s
defined as a correlation coefficient between i-th and j-th bins in a
set of 1D spectra (twelve spectra each acquired on an hourly basis).
A positively (negatively) higher coefficient means the existence of a
positive (negative) correlation between i-th and j-th peaks
throughout the spectra.
Quantification and identification of FAs
Lipids were extracted by shaking cultures with isopropanol-
isooctane-6N H2SO4 (20:10:1), as reported previously [85]. Then,
the lipids were transmethylated with 5% HCl in methanol at 60uC
for 20 min under N2 gas [85]. Methylated FAs were analyzed by
gas chromatography-mass spectrometry (GC-17A, Shimadzu Co.,
Kyoto, Japan) as described previously [85]. In order to identify the
FAs derived from LNA hydrogenation, FAs extracted from
cultures were separated and collected by reversed-phase HPLC
(Prominence, Shimadzu Co., Kyoto, Japan) using COSMOSIL
5C18-AR-II (4.6 mm I.D.6150 mm, Nacalai Tesque Inc., Kyoto,
Japan).
Supporting Information
Figure S1 Glucose concentration and growth rate of three
strains of B. fibrisolvens incubated in NMR tubes. Glucose
concentration (circles) was calculated from the signal intensities
observed every 5 minutes. OD (squares) was determined hourly.
Mean values of triplicate experiments are shown.
Found at: doi:10.1371/journal.pone.0004893.s001 (0.42 MB TIF)
Figure S2 Dependence of pH on chemical shift mobility of
acetate (A) and succinate (B). Mean values of triplicate experiments
are shown.
Found at: doi:10.1371/journal.pone.0004893.s002 (0.16 MB TIF)
Figure S3 Time series of STOCSY analysis of B. fibrisolvens
MDT-10 incubated with or without LNA. During these one-hour
experiments, a total of twelve continuously acquired in vivo
1H-
NMR spectra were used for STOCSY analysis. Contour levels
(STOCSY correlations) defined by different colors are indicated at
the bottom. Blue represents high positive correlation and red
represents low. Data are representative of three independent
experiments.
Found at: doi:10.1371/journal.pone.0004893.s003 (3.06 MB TIF)
Figure S4 LA metabolic dynamics of B. fibrisolvens MDT-10
analyzed by time-dependent 2D-
13C-HSQC RT-MT. B. fibrisol-
vens MDT-10 was anaerobically inoculated in an NMR tube and
U-
13C18 LA (2.5 mM) was added to monitor LA hydrogenation by
in vivo 2D-
13C-HSQC. Mean values of triplicate experiments are
shown. LA (circles), CLA (triangles), VA (squares), and bacterial
growth (open squares) are shown.
Found at: doi:10.1371/journal.pone.0004893.s004 (0.39 MB TIF)
Figure S5 Comparison of 2D-
13C-HSQC spectra obtained from
LNA and its metabolites. Distinct signals are shown by arrows
indicating D
15 double bond (red), cis double bond (purple), and
trans double bond (green). Unidentified 18:2 has trans and cis
double bonds, but no D
15 double bond.
Found at: doi:10.1371/journal.pone.0004893.s005 (0.37 MB TIF)
Figure S6 Comparison of TOCSY spectra of LNA metabolites.
A: CLNA (c9, t11,c15–18:3), B: t11,c15–18:2, C: VA (t11–18:2), D:
Unidentified 18:2. Black line indicates correlation between CH3
(brown square) and CH (green square). It was shown that
unidentified 18:2 exhibits correlation between CH3 and CH,
meaning that one of the double bonds of this FA is located more
closely to the methyl group side than D
11.
Found at: doi:10.1371/journal.pone.0004893.s006 (1.37 MB TIF)
Table S1 Fluctuation of signal intensities of methylene group of
U-
13C18 LA under various in vivo NMR conditions.
Found at: doi:10.1371/journal.pone.0004893.s007 (0.02 MB
DOC)
Table S2 Fluctuation of signal intensities of methylene group of
U-
13C18 LA under various pH conditions.
Found at: doi:10.1371/journal.pone.0004893.s008 (0.02 MB
DOC)
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